SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-132155
Filing Date
2020-12-03
Accepted
2020-12-03 21:41:39
Documents
1
Period of Report
2020-12-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2037705d7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2037705d7_4seq1.xml 4 14663
  Complete submission text file 0001104659-20-132155.txt   16190
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Issuer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROTROPE, INE. 205 EAST 42ND STREET - 20TH FLOOR NEW YORK NY 10017
Business Address
Alkon Daniel L. (Reporting) CIK: 0001686138 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38045 | Film No.: 201368481